MedPath

Closure Of Patent Ductus Arteriosus With the AMPLATZER Duct Occluder the AMPLATZER® Duct Occluder

Not Applicable
Completed
Conditions
Patent Ductus Arteriosus (PDA)
Registration Number
NCT00583596
Lead Sponsor
Abbott Medical Devices
Brief Summary

AGA-004 - The objective of the study is to determine safety, effectiveness and clinical utility of the AMPLATZER Duct Occluder in patients with patent ductus arteriosus. AGA-007 - The objective of this study is to evaluate the long term safety and effectiveness issues that may not have have been adequately addressed during AGA-004.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
436
Inclusion Criteria
  • Patients with a demonstrated patent ductus arteriosus
  • Body weight > 5 Kilograms
Exclusion Criteria
  • Pulmonary vascular resistance above 8 Woods units or a Rp/Rs >0.4.
  • Additional cardiac or non-cardiac abnormality that can reasonably be expected to significantly affect the patient's health adversely in the next two years, i.e.: cancer, Eisenmenger's syndrome, other serious congenital heart disease.
  • Pelvic vein or inferior vena cava thrombosis
  • Sepsis (local/generalized) or any type of infection that cannot be successfully treated prior to device placement.
  • History of repeated pulmonary infection
  • Demonstrated intracardiac thrombi on echocardiography • Inability to obtain informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Reporting of Late Adverse Events Relating to the Device.Long term follow up for data captured at 5, 6 or 7 years post implant
Reporting of Late Efficacy Issues Regarding Patent Ductus Arteriosis (PDA) ClosureLong term follow up data captured at 5, 6 or 7 years post implant

The number of participants with a residual shunt (efficacy)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (23)

University of Alabama

🇺🇸

Birmingham, Alabama, United States

Children's Hospital

🇺🇸

Denver, Colorado, United States

Children's National Medical Center

🇺🇸

Washington, District of Columbia, United States

University of Florida

🇺🇸

Gainesville, Florida, United States

Arnold Palmer Hospital

🇺🇸

Orlando, Florida, United States

University of Chicago

🇺🇸

Chicago, Illinois, United States

Indiana University School of Medicine

🇺🇸

Indianapolis, Indiana, United States

Louisana State University Medical Center

🇺🇸

New Orleans, Louisiana, United States

New England Medical Center

🇺🇸

Boston, Massachusetts, United States

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

Scroll for more (13 remaining)
University of Alabama
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.